Literature DB >> 32997294

Action fluency identifies different sex, age, global cognition, executive function and brain activation profile in non-demented patients with Parkinson's disease.

Noémie Auclair-Ouellet1,2,3,4,5, Alexandru Hanganu6,7,8,9, Erin L Mazerolle6,7,10, Stefan T Lang6,7, Mekale Kibreab6,7, Mehrafarin Ramezani6,7, Angela Haffenden6,7, Tracy Hammer6,7, Jenelle Cheetham6,7, Iris Kathol6,7, G Bruce Pike6,7,10,11, Justyna Sarna6,7, Davide Martino6,7, Oury Monchi6,7,11,12.   

Abstract

Patients with Parkinson's disease (PD) have difficulties processing action words, which could be related to early cognitive decline. The action fluency test can be used to quickly and easily assess the processing of action words in PD. The goal of this study was to characterize how the action fluency test relates to personal characteristics, disease factors, cognition, and neural activity in PD. Forty-eight participants with PD (34 male, 14 female) and 35 control participants (16 male, 19 female) completed functional neuroimaging using a set-shifting task and a neuropsychological assessment including the action fluency test. PD participants with a score one standard deviation below the norm or lower on the action fluency test were identified. All PD participants with poor performance (PD-P, n = 15) were male. They were compared to male PD participants with scores within the normal range (PD-N, n = 19) and male healthy controls (HC, n = 16). PD-P were older, had lower global cognition scores, lower executive functions scores, and decreased activity in fronto-temporal regions compared with PD-N. There was no difference between the two PD groups in terms of the duration of the disease, dose of dopaminergic medication, and severity of motor symptoms. PD-N were younger than HC, but there was no other significant difference between these groups. The action fluency test identified a subgroup of PD patients with distinct sex, age, global cognition, executive functions, and brain activity characteristics. Implications for the evaluation of cognition are discussed.

Entities:  

Keywords:  Action; Cognition; Executive functions; Fluency; Parkinson’s disease; Prefrontal cortex

Mesh:

Year:  2020        PMID: 32997294     DOI: 10.1007/s00415-020-10245-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  57 in total

1.  Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia.

Authors:  A L Piatt; J A Fields; A M Paolo; W C Koller; A I Tröster
Journal:  J Clin Exp Neuropsychol       Date:  1999-08       Impact factor: 2.475

2.  Action verbal fluency normative data for the elderly.

Authors:  Andrea L Piatt; Julie A Fields; Anthony M Paolo; Alexander I Tröster
Journal:  Brain Lang       Date:  2004-06       Impact factor: 2.381

Review 3.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

Review 4.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

5.  Not all words are created equal. Category-specific deficits in central nervous system disease.

Authors:  M Grossman
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

6.  Action fluency in Parkinson's disease: a follow-up study.

Authors:  Matteo Signorini; Chiara Volpato
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

7.  Is action naming better preserved (than object naming) in Alzheimer's disease and why should we ask?

Authors:  Judit Druks; Jackie Masterson; Michael Kopelman; Linda Clare; Anita Rose; Gucharan Rai
Journal:  Brain Lang       Date:  2006-07-14       Impact factor: 2.381

Review 8.  Mild Cognitive Impairment in Parkinson's Disease-What Is It?

Authors:  Rimona S Weil; Alyssa A Costantini; Anette E Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-10       Impact factor: 5.081

Review 9.  Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Authors:  Jennifer G Goldman; Beth A Vernaleo; Richard Camicioli; Nabila Dahodwala; Roseanne D Dobkin; Terry Ellis; James E Galvin; Connie Marras; Jerri Edwards; Julie Fields; Robyn Golden; Jason Karlawish; Bonnie Levin; Lisa Shulman; Glenn Smith; Christine Tangney; Cathi A Thomas; Alexander I Tröster; Ergun Y Uc; Noreen Coyan; Crystal Ellman; Mike Ellman; Charlie Hoffman; Susan Hoffman; Don Simmonds
Journal:  NPJ Parkinsons Dis       Date:  2018-06-26

Review 10.  Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.

Authors:  Antoniya Todorova; Peter Jenner; K Ray Chaudhuri
Journal:  Pract Neurol       Date:  2014-04-03
View more
  1 in total

Review 1.  Action Fluency in Parkinson's Disease: A Mini-Review and Viewpoint.

Authors:  Claudia Gianelli; Carlotta Maiocchi; Nicola Canessa
Journal:  Front Aging Neurosci       Date:  2021-11-25       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.